Christopher Linthwaite

An experienced Senior Executive, Chris joined Thermo Fisher Scientific via the 2014 acquisition of Life Technologies. He is the President of the Genetic Sciences Division, a diversified, $2 billion genetic tools platform (RT-PCR, Sanger and Next Generation Sequencing) useful in the detection and analysis of DNA/RNA for molecular diagnostics, human forensics, and agricultural science applications. Prior to leading this business, Chris transformed Invitrogen’s BioProduction franchise into a market leading cell culture supplier into the biologics manufacturing industry. As an entrepreneur, he founded a therapeutic antibody process development business. As a member of the executive team with BioReliance, he guided marketing, product management, R&D and post merger integration activities for the $130MM toxicology/ biologics testing company.

Early in his career, Chris served as an Armor Officer in the US Army, including peacekeeping tours in Bosnia/ Germany as well as White House Internship. He worked in strategy consulting with Diamond Technology Partners (now part of PwC) and Booz & Company (PwC). Chris earned both an MBA and a BA degree from the University of Virginia.